Disclosure under regulation 29(2) of SEBI(SAST) Regulations, 2011 received from Ishita Pharmaceuticals, related party of Ishita Drugs and Industries Ltd.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ishita Pharmaceuticals, a related party of Ishita Drugs & Industries Ltd, acquired 1,845 equity shares of Rs. 10 each through open market purchases on November 21, 2025. Following this acquisition, Ishita Pharmaceuticals' holding in the company rose from 26,399 shares (0.88%) to 28,244 shares (0.94%), a marginal increase of 0.06%. The disclosure was filed by both Ishita Pharmaceuticals and the company under SEBI's Substantial Acquisition of Shares and Takeovers Regulations, 2011. The total equity share capital of Ishita Drugs & Industries Ltd remains at 29,90,300 shares of Rs. 10 each. This is a small, non-material acquisition that does not indicate any change in control.
This is a minor open market purchase by a related party, representing only 0.06% of total shares. It has negligible impact on the stock price or overall shareholder structure and signals no change in control of the company.